Friday turned out to be a nightmare for shareholders of Juno Therapeutics Inc (NASDAQ:JUNO) and T2 Biosystems Inc (NASDAQ:TTOO), as shares of both companies fell …
Sarepta Therapeutics Inc Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) are on the rise today, after the biotech firm received a request from the FDA to provide additional data …
Heading into the May 26 PDUFA date for an approval or nonapproval of Sarepta Therapeutics Inc’s (NASDAQ:SRPT) Duchenne muscular dystrophy treatment, eteplirsen, WBB Securities …
Moving a pipeline drug from inception to commercialization can take years for biotech companies. Analysts weigh in on upcoming catalysts for Sarepta Therapeutics …
While shares of stem cell company Athersys, Inc. (NASDAQ:ATHX) are trading up over 20% following new partnership agreement in Japan, shares of biotech company Caladrius Biosciences …
WBB Securities analyst Stephen Brozak came out today with a favorable report on Caladrius Biosciences Inc (NASDAQ:CLBS), after the company announced Tuesday that it has signed …
In a research report released today, WBB Securities analyst Stephen Brozak reiterated a Buy rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT), and raised …
Celldex Therapeutics, Inc. (NASDAQ:CLDX) price target has been raised by research analyst Stephen Brozak at WBB Securities.
Sarepta Therapeutics Inc (NASDAQ:SRPT) price target has been raised by research analyst Stephen Brozak at WBB Securities. The new price target now stands …
